A detailed history of Candriam S.C.A. transactions in Baxter International Inc stock. As of the latest transaction made, Candriam S.C.A. holds 32,015 shares of BAX stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,015
Previous 32,015 -0.0%
Holding current value
$1.11 Million
Previous $1.37 Million 21.78%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$37.88 - $43.77 $73,297 - $84,694
1,935 Added 6.43%
32,015 $1.37 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $43,410 - $53,322
-1,369 Reduced 4.35%
30,080 $1.16 Million
Q2 2023

Aug 08, 2023

SELL
$39.98 - $47.68 $1.32 Million - $1.58 Million
-33,051 Reduced 51.24%
31,449 $1.43 Million
Q1 2023

May 12, 2023

SELL
$37.58 - $52.57 $458,701 - $641,669
-12,206 Reduced 15.91%
64,500 $2.62 Million
Q4 2022

Feb 13, 2023

SELL
$49.7 - $57.71 $438,751 - $509,463
-8,828 Reduced 10.32%
76,706 $3.91 Million
Q3 2022

Nov 10, 2022

BUY
$53.86 - $66.8 $2.26 Million - $2.8 Million
41,989 Added 96.43%
85,534 $4.61 Million
Q2 2022

Aug 03, 2022

SELL
$63.83 - $80.0 $24,255 - $30,400
-380 Reduced 0.87%
43,545 $2.8 Million
Q1 2022

May 13, 2022

SELL
$76.85 - $89.45 $24,592 - $28,624
-320 Reduced 0.72%
43,925 $3.41 Million
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $347,272 - $406,043
-4,657 Reduced 9.52%
44,245 $3.8 Million
Q3 2021

Nov 09, 2021

SELL
$73.77 - $83.61 $206,334 - $233,857
-2,797 Reduced 5.41%
48,902 $3.93 Million
Q2 2021

Jul 20, 2021

SELL
$80.5 - $88.01 $5.61 Million - $6.13 Million
-69,647 Reduced 57.4%
51,699 $4.16 Million
Q4 2020

Jan 22, 2021

BUY
$75.39 - $82.36 $5.41 Million - $5.91 Million
71,787 Added 144.85%
121,346 $9.74 Million
Q3 2020

Oct 19, 2020

SELL
$78.33 - $90.73 $137,469 - $159,231
-1,755 Reduced 3.42%
49,559 $3.99 Million
Q2 2020

Jul 23, 2020

SELL
$78.66 - $94.14 $616,143 - $737,398
-7,833 Reduced 13.24%
51,314 $4.42 Million
Q1 2020

May 26, 2020

BUY
$71.57 - $93.3 $644 - $839
9 Added 0.02%
59,147 $4.84 Million
Q4 2019

Jan 21, 2020

BUY
$76.7 - $88.45 $95,951 - $110,650
1,251 Added 2.16%
59,138 $5,000
Q3 2019

Feb 05, 2020

SELL
$81.4 - $89.78 $814 - $897
-10 Reduced 0.02%
57,887 $5.06 Million
Q3 2019

Oct 21, 2019

SELL
$81.4 - $89.78 $1.31 Million - $1.45 Million
-16,149 Reduced 21.81%
57,897 $6,000
Q2 2019

Aug 01, 2019

BUY
$73.44 - $82.41 $1.85 Million - $2.07 Million
25,154 Added 51.45%
74,046 $7.67 Million
Q1 2019

May 02, 2019

SELL
$64.48 - $81.31 $1,354 - $1,707
-21 Reduced 0.04%
48,892 $3.98 Million
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $707,105 - $895,244
11,507 Added 30.76%
48,913 $3.22 Million
Q3 2018

Nov 07, 2018

SELL
$70.71 - $77.75 $52,466 - $57,690
-742 Reduced 1.95%
37,406 $2.88 Million
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $137,706 - $163,715
-2,171 Reduced 5.38%
38,148 $2.82 Million
Q1 2018

May 09, 2018

SELL
$62.56 - $72.26 $944,656 - $1.09 Million
-15,100 Reduced 27.25%
40,319 $2.62 Million
Q4 2017

Feb 07, 2018

SELL
$61.45 - $66.05 $1.02 Million - $1.1 Million
-16,635 Reduced 23.09%
55,419 $3.58 Million
Q3 2017

Nov 03, 2017

BUY
$59.5 - $64.61 $4.29 Million - $4.66 Million
72,054
72,054 $4.52 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.